October 13, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attention: Courtney Lindsay
Praxis Precision Medicines, Inc.
Acceleration Request for Registration Statement on Form S-1
File No. 333-249074
Ladies and Gentlemen,
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the Act), Praxis Precision Medicines, Inc. (the Company) hereby requests that the effective date of the above-referenced registration statement (the Registration Statement) be accelerated to October 15, 2020, at 4:01 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP by calling William D. Collins at (617) 570-1447. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: William D. Collins, by facsimile to (617) 321-4422.
If you have any questions regarding this request, please contact William D. Collins of Goodwin Procter LLP at (617) 570-1447.
|PRAXIS PRECISION MEDICINES, INC.|
Chief Executive Officer
Stuart Chaffee, Praxis Precision Medicines, Inc.
Richard A. Hoffman, Esq., Goodwin Procter LLP
Edwin OConnor, Esq., Goodwin Procter LLP
William D. Collins, Esq., Goodwin Procter LLP
[Signature Page to Acceleration Request]